St. Louis-based startup Kypha has raised $4 million in a Series A round led by St. Louis-based venture capital firm Arsenal Capital Management.
The company, which makes medical diagnostics tools, plans to use the funding to expand its facilities in Ireland, support the launch of new tests and grow partnerships with pharmaceutical companies, according to a press release.
This is Kypha’s third round of funding led by Arsenal.
The capital raise comes at the end of a year in which Kypha acquired Biosensia, an Irish company. Kypha CEO Chad Stiening described 2018 as “transformative” for the company.